ranQ
ranQ
ranQ
DirectoryIndustriesKnowledgeComparisonsSoon
Sign inCheck visibility
ranQHSG Startup LabelRecognised by the
HSG Startup Label

The first Swiss company directory, built to boost AI visibility.

Product
  • Pricing
  • Directory
  • Industries
Company
  • About
  • Contact
  • Legal
© 2026 cohaga AG · All Rights Reserved · St. Gallen, Switzerland · Imprint742,806 companies indexed · Last updated: today
DirectoryIndustryPharmaceutical IndustrySchlierenBaxiva AG
Baxiva AG Logo
Verified· 3 sources

Baxiva AG

Summary

About the company

Baxiva AG develops glycoconjugate vaccines for the prevention of bacterial infections. Its platform chemically links serotype-specific bacterial polysaccharides to virus-like particles (VLPs) to generate immunogenic, multivalent vaccine candidates against Gram-negative pathogens such as Escherichia coli.

AI-generated
Offering

Products & services

Industry:Pharmaceutical Industry
LeadhubOutbound Leads by COHAGA

Looking for direct email addresses and phone numbers?

Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.

Discover Leadhub
✓ Offered2
Development of glycoconjugate vaccines
Development of vaccines against bacterial infections using serotype-specific polysaccharides from Gram-negative bacteria and proprietary chemical conjugation with virus-like particles.
Vaccine platform for multivalent bacterial target pathogens
Platform for the rapid development of highly multivalent vaccines against known and newly emerging bacterial pathogens, focusing on Gram-negative bacteria and resistance issues.
Press

Media

February 23, 2026Media
Baxiva receives CHF 150,000 from Venture Kick to develop first-in-class Escherichia Coli vaccine
startupticker.ch
August 22, 2025Media
Baxiva secures $3 million to advance antibacterial vaccines
startupticker.ch

Knowledge

No knowledge articles yet

Once Baxiva AG has claimed this profile, we'll publish editorial articles and case studies here together.

Get started
Comparisons

Baxiva AG in comparison

Soon

Industry comparisons are coming soon

We're preparing industry comparisons that rank Baxiva AG by reviews, experience and specialisations.

Is this your company?

Claim the company profile of Baxiva AG to make its contact details visible. With a plan we additionally create and publish industry comparisons, articles and much more.

Secure profile

Location

Südstrasse 1
8952 Schlieren

At a glance

Legal form
Corporation
UID
CHE-349.898.114
Founded
2025 · 1 year
Last commercial register change
February 19, 2026
Employees
1 to 10

Similar companies

TP
Takeda Pharma AG
Glattpark (Opfikon)
TP
Topadur Pharma AG
Schlieren
BA
Baxter AG
Glattpark (Opfikon)
ET
Endogena Therapeutics AG
Zurich